GE HealthCare's EPS guidance for 2024 is closely aligned with market expectations, indicating management's confidence in the company's financial performance and growth prospects. This alignment with consensus estimates is likely to be viewed positively by investors, as it suggests stability and potential for growth, supporting a positive short-term impact on the stock price.